Patients, clinicians seek answers to the mystery of ‘Long COVID’ – CIDRAP
The post Patients, clinicians seek answers to the mystery of ‘Long COVID’ appeared first on Links Medicus.
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine – JAMA Author interview: COVID-19 Vaccine Safety–Anaphylaxis and Allergic Reactions
The post Clinical update: Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine appeared first on Links Medicus.
Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study – Canadian Medical Association Journal Commentaries: Analysis of patient data reveals most common complications of COVID-19 – Medical News Today AND Study confirms most common complications associated with COVID-19 – New Medical Commentary on Twitter Large study of patients in the US who contracted #COVID19 confirms […]
The post Large cohort study identifies the most common hospital complications associated with COVID-19 appeared first on Links Medicus.
Airborne Transmission of SARS-CoV-2: What We Know – Clinical Infectious Diseases Commentary on Twitter Our workshop summary on airborne transmission of SARS-CoV-2 is out. Thanks to all the leading scientists who helped lead this amazing and impactful workshop! @theNASEM @linseymarr @kprather88 @Lakdawala_Lab https://t.co/MKfNA0QatN — John Volckens (@Smogdr) January 18, 2021
The post Airborne transmission of SARS-CoV-2: What we know appeared first on Links Medicus.
Lilly’s neutralizing antibody bamlanivimab (LY-CoV555) prevented COVID-19 at nursing homes in the BLAZE-2 trial, reducing risk by up to 80 percent for residents Commentaries: Eli Lilly says its monoclonal antibody prevented Covid-19 infections in clinical trial – STAT AND Expert reaction to press release from Lilly about their neutralising antibody bamlanivimab and results from the […]
The post [News release – Not published yet] Lilly’s neutralizing antibody prevented COVID-19 at nursing homes, reducing risk by up to 80 percent for residents appeared first on Links Medicus.
Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure – New England Journal of Medicine (link to abstract – $ for full-text) Commentary on Twitter Even though supplemental oxygen is used for the treatment of patients with hypoxemic respiratory failure, the most effective oxygenation targets are not known. In this randomized trial, a […]
The post Randomized trial: Similar outcomes with lower vs. higher oxygenation targets for acute hypoxemic respiratory failure appeared first on Links Medicus.
Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis – JAMA Internal Medicine Related: The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs: A Systematic Review and Meta-analysis – Annals of Internal Medicine
The post Meta-analysis: saliva and nasopharyngeal swab nucleic acid amplification have similar diagnostic accuracy for the detection of SARS-CoV-2 appeared first on Links Medicus.
Covid-19: What new variants are emerging and how are they being investigated? – The BMJ
The post Covid-19: What new variants are emerging and how are they being investigated? appeared first on Links Medicus.
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study – The Lancet Respiratory Medicine Commentaries: Improving clinical management of COVID-19: the role of prediction models – The Lancet Respiratory Medicine Tool identifies COVID-19 patients at highest risk of deterioration – UK Research and Innovation See calculator: […]
The post New calculator identifies COVID-19 patients at highest risk of deterioration appeared first on Links Medicus.
COVID-19 Diagnostic Guidelines Updates (Jan. 16, 2021) – Infectious Diseases Society of America
The post IDSA: COVID-19 Diagnostic Guidelines Updates appeared first on Links Medicus.